Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization
- Autores
- Blanco, Sebastian; Giacomi, Virginia Soledad; Slobodianiuk, Luciano Gabriel; Frutos, Maria Celia; Carrizo, Luis Horacio; Fanin, Gabriela Elvira; Culasso, Jorge Mario; Gallego, Sandra Veronica
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Introduction: Since anti-D immunoprophylaxis given to D-negative pregnant women is a blood product, blood donations have an impact on the availability of prophylactic doses. The Pan American Health Organization reported, in June 2017, that less than half of blood donors are volunteers in Latin America and the Caribbean. In these countries, guidelines for use of anti-D prophylaxis are still controversial. The aim of this study was to demonstrate the convenience of a simple and cost-effectivene non-invasive prenatal diagnostic assay for anti-D prophylaxis optimization in multiethnic populations. Methods: Cell-free fetal DNA from plasma samples of D-negative pregnant women were analyzed by real-time PCR for simultaneous amplification of sequences of exons 5 and 10 of the RHD gene. Fetal RHD genotype was determined in 111 pregnant women. Neonates' phenotype was determined 72 h after birth. Results: Genotyping predicted fetal phenotype with 100% accuracy. Prenatal diagnosis showed 78% RHD-positive and 22% RHD-negative neonates. Conclusion: We demonstrated that, beyond the large genetic variation of the Rh system and the numerous D variants present in multiethnic groups, non-invasive fetal RHD genotyping using two sequences of the gene can be enough for clinical application in an admixed population. This robust technique of simple implementation allows to determine fetal RHD in maternal blood with high sensitivity, specificity, and accuracy. The introduction of fetal RhD genotyping as part of an antenatal screening program constitutes a reliable manner to optimize anti-D prophylaxis; however, it has not been implemented so far in most American countries.
Fil: Blanco, Sebastian. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; Argentina
Fil: Giacomi, Virginia Soledad. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina
Fil: Slobodianiuk, Luciano Gabriel. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina
Fil: Frutos, Maria Celia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina
Fil: Carrizo, Luis Horacio. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina
Fil: Fanin, Gabriela Elvira. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina
Fil: Culasso, Jorge Mario. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina
Fil: Gallego, Sandra Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; Argentina - Materia
-
ANTENATAL IMMUNOPROPHYLAXIS
FETAL RHD GENOTYPING
HEMOLYTIC DISEASE OF THE NEWBORN
MOLECULAR BLOOD GROUP TYPING
NON-INVASIVE PRENATAL DIAGNOSIS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/164419
Ver los metadatos del registro completo
id |
CONICETDig_2200703051b579b4cd0958ca451e38bb |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/164419 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis OptimizationBlanco, SebastianGiacomi, Virginia SoledadSlobodianiuk, Luciano GabrielFrutos, Maria CeliaCarrizo, Luis HoracioFanin, Gabriela ElviraCulasso, Jorge MarioGallego, Sandra VeronicaANTENATAL IMMUNOPROPHYLAXISFETAL RHD GENOTYPINGHEMOLYTIC DISEASE OF THE NEWBORNMOLECULAR BLOOD GROUP TYPINGNON-INVASIVE PRENATAL DIAGNOSIShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Introduction: Since anti-D immunoprophylaxis given to D-negative pregnant women is a blood product, blood donations have an impact on the availability of prophylactic doses. The Pan American Health Organization reported, in June 2017, that less than half of blood donors are volunteers in Latin America and the Caribbean. In these countries, guidelines for use of anti-D prophylaxis are still controversial. The aim of this study was to demonstrate the convenience of a simple and cost-effectivene non-invasive prenatal diagnostic assay for anti-D prophylaxis optimization in multiethnic populations. Methods: Cell-free fetal DNA from plasma samples of D-negative pregnant women were analyzed by real-time PCR for simultaneous amplification of sequences of exons 5 and 10 of the RHD gene. Fetal RHD genotype was determined in 111 pregnant women. Neonates' phenotype was determined 72 h after birth. Results: Genotyping predicted fetal phenotype with 100% accuracy. Prenatal diagnosis showed 78% RHD-positive and 22% RHD-negative neonates. Conclusion: We demonstrated that, beyond the large genetic variation of the Rh system and the numerous D variants present in multiethnic groups, non-invasive fetal RHD genotyping using two sequences of the gene can be enough for clinical application in an admixed population. This robust technique of simple implementation allows to determine fetal RHD in maternal blood with high sensitivity, specificity, and accuracy. The introduction of fetal RhD genotyping as part of an antenatal screening program constitutes a reliable manner to optimize anti-D prophylaxis; however, it has not been implemented so far in most American countries.Fil: Blanco, Sebastian. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; ArgentinaFil: Giacomi, Virginia Soledad. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; ArgentinaFil: Slobodianiuk, Luciano Gabriel. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; ArgentinaFil: Frutos, Maria Celia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; ArgentinaFil: Carrizo, Luis Horacio. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; ArgentinaFil: Fanin, Gabriela Elvira. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; ArgentinaFil: Culasso, Jorge Mario. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; ArgentinaFil: Gallego, Sandra Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; ArgentinaKarger2018-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/164419Blanco, Sebastian; Giacomi, Virginia Soledad; Slobodianiuk, Luciano Gabriel; Frutos, Maria Celia; Carrizo, Luis Horacio; et al.; Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization; Karger; Transfusion Medicine And Hemotherapy; 45; 6; 11-2018; 423-4281660-37961660-3818CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.karger.com/Article/FullText/490156info:eu-repo/semantics/altIdentifier/doi/10.1159/000490156info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:26:31Zoai:ri.conicet.gov.ar:11336/164419instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:26:31.778CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
title |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
spellingShingle |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization Blanco, Sebastian ANTENATAL IMMUNOPROPHYLAXIS FETAL RHD GENOTYPING HEMOLYTIC DISEASE OF THE NEWBORN MOLECULAR BLOOD GROUP TYPING NON-INVASIVE PRENATAL DIAGNOSIS |
title_short |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
title_full |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
title_fullStr |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
title_full_unstemmed |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
title_sort |
Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
dc.creator.none.fl_str_mv |
Blanco, Sebastian Giacomi, Virginia Soledad Slobodianiuk, Luciano Gabriel Frutos, Maria Celia Carrizo, Luis Horacio Fanin, Gabriela Elvira Culasso, Jorge Mario Gallego, Sandra Veronica |
author |
Blanco, Sebastian |
author_facet |
Blanco, Sebastian Giacomi, Virginia Soledad Slobodianiuk, Luciano Gabriel Frutos, Maria Celia Carrizo, Luis Horacio Fanin, Gabriela Elvira Culasso, Jorge Mario Gallego, Sandra Veronica |
author_role |
author |
author2 |
Giacomi, Virginia Soledad Slobodianiuk, Luciano Gabriel Frutos, Maria Celia Carrizo, Luis Horacio Fanin, Gabriela Elvira Culasso, Jorge Mario Gallego, Sandra Veronica |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
ANTENATAL IMMUNOPROPHYLAXIS FETAL RHD GENOTYPING HEMOLYTIC DISEASE OF THE NEWBORN MOLECULAR BLOOD GROUP TYPING NON-INVASIVE PRENATAL DIAGNOSIS |
topic |
ANTENATAL IMMUNOPROPHYLAXIS FETAL RHD GENOTYPING HEMOLYTIC DISEASE OF THE NEWBORN MOLECULAR BLOOD GROUP TYPING NON-INVASIVE PRENATAL DIAGNOSIS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Introduction: Since anti-D immunoprophylaxis given to D-negative pregnant women is a blood product, blood donations have an impact on the availability of prophylactic doses. The Pan American Health Organization reported, in June 2017, that less than half of blood donors are volunteers in Latin America and the Caribbean. In these countries, guidelines for use of anti-D prophylaxis are still controversial. The aim of this study was to demonstrate the convenience of a simple and cost-effectivene non-invasive prenatal diagnostic assay for anti-D prophylaxis optimization in multiethnic populations. Methods: Cell-free fetal DNA from plasma samples of D-negative pregnant women were analyzed by real-time PCR for simultaneous amplification of sequences of exons 5 and 10 of the RHD gene. Fetal RHD genotype was determined in 111 pregnant women. Neonates' phenotype was determined 72 h after birth. Results: Genotyping predicted fetal phenotype with 100% accuracy. Prenatal diagnosis showed 78% RHD-positive and 22% RHD-negative neonates. Conclusion: We demonstrated that, beyond the large genetic variation of the Rh system and the numerous D variants present in multiethnic groups, non-invasive fetal RHD genotyping using two sequences of the gene can be enough for clinical application in an admixed population. This robust technique of simple implementation allows to determine fetal RHD in maternal blood with high sensitivity, specificity, and accuracy. The introduction of fetal RhD genotyping as part of an antenatal screening program constitutes a reliable manner to optimize anti-D prophylaxis; however, it has not been implemented so far in most American countries. Fil: Blanco, Sebastian. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; Argentina Fil: Giacomi, Virginia Soledad. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina Fil: Slobodianiuk, Luciano Gabriel. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina Fil: Frutos, Maria Celia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina Fil: Carrizo, Luis Horacio. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina Fil: Fanin, Gabriela Elvira. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina Fil: Culasso, Jorge Mario. Fundación Banco Central de Sangre; Argentina. Hospital Materno-Provincial Dr. Raúl Felipe Lucini; Argentina Fil: Gallego, Sandra Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Fundación Banco Central de Sangre; Argentina |
description |
Introduction: Since anti-D immunoprophylaxis given to D-negative pregnant women is a blood product, blood donations have an impact on the availability of prophylactic doses. The Pan American Health Organization reported, in June 2017, that less than half of blood donors are volunteers in Latin America and the Caribbean. In these countries, guidelines for use of anti-D prophylaxis are still controversial. The aim of this study was to demonstrate the convenience of a simple and cost-effectivene non-invasive prenatal diagnostic assay for anti-D prophylaxis optimization in multiethnic populations. Methods: Cell-free fetal DNA from plasma samples of D-negative pregnant women were analyzed by real-time PCR for simultaneous amplification of sequences of exons 5 and 10 of the RHD gene. Fetal RHD genotype was determined in 111 pregnant women. Neonates' phenotype was determined 72 h after birth. Results: Genotyping predicted fetal phenotype with 100% accuracy. Prenatal diagnosis showed 78% RHD-positive and 22% RHD-negative neonates. Conclusion: We demonstrated that, beyond the large genetic variation of the Rh system and the numerous D variants present in multiethnic groups, non-invasive fetal RHD genotyping using two sequences of the gene can be enough for clinical application in an admixed population. This robust technique of simple implementation allows to determine fetal RHD in maternal blood with high sensitivity, specificity, and accuracy. The introduction of fetal RhD genotyping as part of an antenatal screening program constitutes a reliable manner to optimize anti-D prophylaxis; however, it has not been implemented so far in most American countries. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/164419 Blanco, Sebastian; Giacomi, Virginia Soledad; Slobodianiuk, Luciano Gabriel; Frutos, Maria Celia; Carrizo, Luis Horacio; et al.; Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization; Karger; Transfusion Medicine And Hemotherapy; 45; 6; 11-2018; 423-428 1660-3796 1660-3818 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/164419 |
identifier_str_mv |
Blanco, Sebastian; Giacomi, Virginia Soledad; Slobodianiuk, Luciano Gabriel; Frutos, Maria Celia; Carrizo, Luis Horacio; et al.; Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization; Karger; Transfusion Medicine And Hemotherapy; 45; 6; 11-2018; 423-428 1660-3796 1660-3818 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.karger.com/Article/FullText/490156 info:eu-repo/semantics/altIdentifier/doi/10.1159/000490156 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Karger |
publisher.none.fl_str_mv |
Karger |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614266776190976 |
score |
13.070432 |